SANTA CLARA and REDWOOD SHORES, CALIFORNIA, USA & LONDON, UK – November 14, 2012
– Acunetix, a market leader in web application security technology, and Imperva, Inc. (NYSE: IMPV) a pioneer and leader of a new category of business security solutions for critical applications and high-value data, today announced that Acunetix Web Vulnerability Scan (WVS) results can now be imported into the SecureSphere Web Application Firewall (WAF) to automatically configure settings that will mitigate the discovered vulnerabilities.
When web application weaknesses such as SQL Injection or Cross Site Scripting are detected by Acunetix WVS, SecureSphere will transform the results into WAF security policies that offer immediate protection to companies needing the time to deal with and fix the security vulnerabilities and not be at risk in the meantime.
Using Acunetix WVS scan results to automate WAF configuration is designed to reduce workload and user errors when compared to manually configuring a web application firewall such as SecureSphere.
“Many Imperva customers use Acunetix WVS to uncover web vulnerabilities,” said Imperva CTO, Amichai Shulman. “We believe that the interoperability of the SecureSphere WAF with Acunetix WVS will allow our customers to mitigate those vulnerabilities quickly and reduce costly data breaches.”
“Acunetix sets a high standard when it comes to discovering web application vulnerabilities. We recommend using a web application firewall like SecureSphere to protect web applications until vulnerabilities can be dealt with directly,” said Nick Galea, Acunetix CEO.
Expected benefits of the interoperability of the SecureSphere WAF with Acunetix WVS are as follows:
Reduced Risk Exposure
– Vulnerabilities are mitigated before developers and testers can fix the web application’s code, thus shortening the Time-to-Fix.
– Virtual patching policies are created automatically, reducing the risk of configuration errors that can lead to false positive or negative alerts.
Reduced Development Cost
– Spend less development resources in emergency situations, fix code vulnerabilities during the normal release cycle.
– Show auditors that vulnerabilities are virtually patched thanks to detailed WAF configuration reports.
Acunetix was founded in 2004 to combat the alarming rise in web attacks. Its flagship product, Acunetix Web Vulnerability Scanner (WVS), is the result of several years of work by a team of highly experienced security developers. Leading International companies and organisations such as NASA, the US Air Force, The Pentagon, PricewaterhouseCoopers and Sony use Acunetix WVS to protect their websites and web applications. Acunetix WVS has won numerous awards including the WindowSecurity.com Web Application Security award for four times in succession. Acunetix is a privately held European company with offices in the UK, Cyprus and Malta. For more information on Acunetix and to download the trial, visit www.acunetix.com.
Imperva is a pioneer and leader of a new category of business security solutions for critical applications and high-value data in the data center. Imperva’s award-winning solutions protect against data theft, insider abuse, and fraud while streamlining regulatory compliance by monitoring and controlling data usage and business transactions across the data center, from storage in a database or on a file server to consumption through applications. With over 2,000 end-user customers in more than 60 countries and thousands of organizations protected through cloud-based deployments, securing your business with Imperva puts you in the company of the world’s leading organizations. For more information, visit www.imperva.com, follow us on Twitter or visit our blog. We’re hiring! Help us protect the world’s data: http://www.imperva.com/go/jobs.
Forward Looking Statements
This news release contains forward-looking statements, including without limitation those regarding the benefits of using SecureSphere Web Application Firewall with Acunetix WVS. These forward-looking statements are subject to material risks and uncertainties that may cause actual results to differ substantially from expectations. You should consider important risk factors, which include: the risk that our products are not adopted at levels that we anticipate; the risk that our partnership between Imperva and Acunetix does not continue; the risk that competitors may be perceived by customers to be better positioned to help handle application security concerns; and other risks detailed under the caption “Risk Factors” in Imperva’s Form 10-Q filed with the Securities and Exchange Commission, or the SEC, on August 13, 2012 and Imperva’s other SEC filings. You can obtain copies of Imperva’s SEC filings on the SEC’s website at www.sec.gov. We undertake no obligation to update any of the forward-looking statements contained herein after the date of this release, whether as a result of new information, future events or otherwise.
© 2012 Imperva, Inc. and Acunetix, Ltd. All rights reserved. Imperva, the Imperva logo and SecureSphere are trademarks of Imperva, Inc. Acunetix and the Acunetix logo are the trademarks of Acunetix, Ltd.